Failure of Guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to Inhibit Replication of Hepatitis A Virus in Vitro
Overview
Authors
Affiliations
Replication of hepatitis A virus (HAV) in the human hepatoma-derived PLC/PRF/5 cell line was neither inhibited in the presence of various concentrations of guanidine or D-2-(alpha-hydroxybenzyl)benzimidazole (D-HBB), nor were the two chemicals effective in combination. Under identical conditions, however, replication of poliovirus type 1 was inhibited. Tracer experiments with radiolabelled guanidine and D-HBB also furnished no evidence that the two antiviral substances were metabolized gradually to inactive derivatives in PLC/PRF/5 cells. Therefore, it is concluded that resistance to the action of guanidine and D-HBB is an inherent characteristic of HAV. However, the insensitivity of HAV to these drugs does not exclude the virus from the family of picornaviruses.
Amoroso M, Di Concilio D, Langellotti A, Martello A, Cioffi B, Suffredini E Food Environ Virol. 2021; 13(3):329-336.
PMID: 33730340 DOI: 10.1007/s12560-021-09470-4.
Molecular biology and inhibitors of hepatitis A virus.
Debing Y, Neyts J, Thibaut H Med Res Rev. 2013; 34(5):895-917.
PMID: 23722879 PMC: 7168461. DOI: 10.1002/med.21292.
Effect of ribavirin on hepatitis A virus replication in vitro.
Chaudhary R, Andonov A Can J Infect Dis. 2012; 3(2):67-70.
PMID: 22529734 PMC: 3328025. DOI: 10.1155/1992/531837.
Yi M, Lemon S J Virol. 2002; 76(3):1171-80.
PMID: 11773393 PMC: 135777. DOI: 10.1128/jvi.76.3.1171-1180.2002.
Carrasco L Pharmacol Ther. 1994; 64(2):215-90.
PMID: 7533301 PMC: 7133639. DOI: 10.1016/0163-7258(94)90040-x.